MacroGenics Inc.

Last updated September 27, 2026

Organization details

Legal name
MacroGenics Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
MGNX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001125345

Board of directors

Chief executives

Scott Koenig ยท President and CEO
Dates unknown

Board connections

7 of this board's directors also sit on 7 other boards.

Network of MacroGenics Inc.'s board connections Crescent Biopharma Inc. Crescent Biopharma Inc... Atara Biotherapeutics Inc. Atara Biotherapeutics... Cogent Biosciences Inc. Cogent Biosciences Inc... Dyne Therapeutics Inc. Dyne Therapeutics Inc. REGENXBIO Inc. REGENXBIO Inc. Spero Therapeutics Inc. Spero Therapeutics Inc... TELA Bio Inc. TELA Bio Inc. David C. Stump David C. Stump Edward Hurwitz Edward Hurwitz Federica F. O'Brien Federica F. O'Brien Karen Jean Ferrante Karen Jean Ferrante Scott Koenig Scott Koenig Scott Thomas Jackson Scott Thomas Jackson William K. Heiden William K. Heiden MacroGenics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 23, 2024 Scott Koenig Director, Officer (President and CEO) Gift โˆ’374,215 โ€” โ€”
Sep 23, 2024 Scott Koenig Director, Officer (President and CEO) Gift +374,215 โ€” โ€”
May 20, 2024 Jay Philip Siegel Director Option exercise +4,500 โ€” โ€”
May 20, 2024 William K. Heiden Director Option exercise +4,500 โ€” โ€”
May 20, 2024 Scott Thomas Jackson Director Option exercise +4,500 โ€” โ€”
May 20, 2024 David C. Stump Director Option exercise +4,500 โ€” โ€”
May 20, 2024 Federica F. O'Brien Director Option exercise +4,500 โ€” โ€”
May 20, 2024 Margaret Liu Director Option exercise +4,500 โ€” โ€”
May 20, 2024 Meenu Chhabra Director Option exercise +4,500 โ€” โ€”
May 20, 2024 Karen Jean Ferrante Director Option exercise +4,500 โ€” โ€”
May 20, 2024 Edward Hurwitz Director Option exercise +4,500 โ€” โ€”
Apr 4, 2024 Peters Jeffrey Stuart Officer (Senior VP and General Counsel) Option exercise +42,500 $4.82 $204,850
Apr 4, 2024 Peters Jeffrey Stuart Officer (Senior VP and General Counsel) Open-market sale โˆ’42,500 $15.07 $640,475
Apr 4, 2024 Peters Jeffrey Stuart Officer (Senior VP and General Counsel) Open-market sale โˆ’147 $15.51 $2,280
Apr 4, 2024 Peters Jeffrey Stuart Officer (Senior VP and General Counsel) Open-market sale โˆ’232 $16.38 $3,800

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.